scholarly journals COVID-19 and Open Notes: A New Method to Enhance Patient Safety and Trust (Preprint)

2021 ◽  
Author(s):  
Charlotte Blease ◽  
Liz Salmi ◽  
Maria Hagglund ◽  
Deborah Wachenheim ◽  
Catherine DesRoches

UNSTRUCTURED From April 5, 2021, as part of the 21st Century Cures Act, all providers in the US must offer patients access to the medical information housed in their electronic records. Via secure health portals, patients can login to access lab and test results, lists of prescribed medications, referral appointments, and the narrative reports written by clinicians (so-called ‘open notes’). As US providers implement this practice innovation, we describe six promising ways in which patient access to their notes might help address problems that either emerged with, or were exacerbated, by the COVID-19 pandemic

2018 ◽  
Vol 25 (9) ◽  
pp. 1218-1220 ◽  
Author(s):  
Carolyn T Lye ◽  
Howard P Forman ◽  
Jodi G Daniel ◽  
Harlan M Krumholz

Abstract While federal regulation provides patients the right to access their electronic health records and promotes increased use of health information technology, patient access to electronic health records remains limited. The 21st Century Cures Act, signed into law over a year ago, has important provisions that could significantly improve access and availability of health data. Specifically, the provisions call for partnerships among health information exchange networks, educational and research initiatives, and health information technology certification requirements that encourage interoperability. The article reviews the potential benefits and concerns regarding implementation of these provisions, particularly the difficulty of aligning incentives and requirements for data sharing and the question of whether currently proposed rules and guidance will support the goal of improved patient access and health information exchange. Researchers, clinicians, and patients have the power to advocate for improved patient access and interoperability as policy development and implementation of the 21st Century Cures Act continues.


2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Davinder Garewal ◽  
Pallavi Waikar

Propofol sedation for endoscopic retrograde cholangiopancreatography (ERCP) procedures is a popular current technique that has generated controversy in the medical field. Worldwide, both anesthetic and nonanesthetic personnel administer this form of sedation. Although the American and Canadian societies of gastroenterologists have endorsed the administration of propofol by nonanesthesia personnel, the US Food and Drug Administration (FDA) has not licensed its use in this manner. There is some evidence for the safe use of propofol by nonanesthetic personnel in patients undergoing endoscopy procedures, but there are few randomized trials addressing the safety and efficacy of propofol in patients undergoing ERCP procedures. A serious possible consequence of propofol sedation in patients is that it may result in rapid and unpredictable progression from deep sedation to general anesthesia, and skilled airway support may be required as a rescue measure. Potential complications following deep propofol sedation include hypoxemia and hypotension. Propofol sedation for ERCP procedures is an area of clinical practice where discussion and mutual cooperation between anesthesia and nonanesthesia personnel may enhance patient safety.


2006 ◽  
Vol 21 (10) ◽  
pp. 1075-1078 ◽  
Author(s):  
Sharon Sung ◽  
Valerie Forman-Hoffman ◽  
Mark C. Wilson ◽  
Peter Cram

10.2196/29314 ◽  
2021 ◽  
Author(s):  
Charlotte Blease ◽  
Liz Salmi ◽  
Maria Hagglund ◽  
Deborah Wachenheim ◽  
Catherine DesRoches

2021 ◽  
Vol 19 (4) ◽  
pp. 378-384
Author(s):  
Leigh Gallo ◽  
Ronald S. Walters ◽  
Jeff Allen ◽  
Jenny Ahlstrom ◽  
Clay Alspach ◽  
...  

The 21st Century Cures Act (Cures Act), signed into law in 2016, was designed to advance new therapies by modernizing clinical trials, funding research initiatives, and accelerating the development and use of health information technology. To analyze the current issues in cancer care related to the implementation and impact of the Cures Act, NCCN convened a multistakeholder working group. Participants discussed the legislation’s impact on the oncology community since enactment and identified the remaining gaps and challenges as experienced by stakeholders. In June 2020, the policy recommendations of the working group were presented at the virtual NCCN Policy Summit: Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020. The summit consisted of informative discussions and a multistakeholder panel to explore the recommendations and the future of the Cures Act. This article explores identified policy recommendations from the NCCN Working Group and the NCCN Policy Summit, and analyzes opportunities to advance innovative cancer care and patient access to data.


Sign in / Sign up

Export Citation Format

Share Document